John W Hinds[Author] - Search Results

Year	Number of Results
2011	1
2012	1
2013	1
2018	1
2019	1
2020	2
2021	2
2022	1
2024	0

1

Formation of a structurally-stable conformation by the intrinsically disordered MYC:TRRAP complex.

Feris EJ, Hinds JW, Cole MD. Feris EJ, et al. Among authors: hinds jw. PLoS One. 2019 Dec 2;14(12):e0225784. doi: 10.1371/journal.pone.0225784. eCollection 2019. PLoS One. 2019. PMID: 31790487 Free PMC article.

2

S146L in MYC is a context-dependent activating substitution in cancer development.

Hinds JW, Feris EJ, Wilkins OM, Deary LT, Wang X, Cole MD. Hinds JW, et al. PLoS One. 2022 Aug 26;17(8):e0272771. doi: 10.1371/journal.pone.0272771. eCollection 2022. PLoS One. 2022. PMID: 36018850 Free PMC article.

3

Luminescence complementation technology for the identification of MYC:TRRAP inhibitors.

Feris EJ, Hinds JW, Cole MD. Feris EJ, et al. Among authors: hinds jw. Oncotarget. 2021 Oct 12;12(21):2147-2157. doi: 10.18632/oncotarget.28078. eCollection 2021 Oct 12. Oncotarget. 2021. PMID: 34676047 Free PMC article.

4

Therapeutically targeting tumor microenvironment-mediated drug resistance in estrogen receptor-positive breast cancer.

Shee K, Yang W, Hinds JW, Hampsch RA, Varn FS, Traphagen NA, Patel K, Cheng C, Jenkins NP, Kettenbach AN, Demidenko E, Owens P, Faber AC, Golub TR, Straussman R, Miller TW. Shee K, et al. Among authors: hinds jw. J Exp Med. 2018 Mar 5;215(3):895-910. doi: 10.1084/jem.20171818. Epub 2018 Feb 7. J Exp Med. 2018. PMID: 29436393 Free PMC article.

5

C3'/C4'-Stereochemical Effects of Digitoxigenin α-L-/α-D-Glycoside in Cancer Cytotoxicity.

Hinds JW, McKenna SB, Sharif EU, Wang HY, Akhmedov NG, O'Doherty GA. Hinds JW, et al. ChemMedChem. 2013 Jan;8(1):63-9. doi: 10.1002/cmdc.201200465. Epub 2012 Nov 8. ChemMedChem. 2013. PMID: 23139074

6

Inhibition of Protein Synthesis Induced by CHK1 Inhibitors Discriminates Sensitive from Resistant Cancer Cells.

Hinds JW, Ditano JP, Eastman A. Hinds JW, et al. ACS Pharmacol Transl Sci. 2021 Aug 4;4(4):1449-1461. doi: 10.1021/acsptsci.1c00150. eCollection 2021 Aug 13. ACS Pharmacol Transl Sci. 2021. PMID: 34423276 Free PMC article.

7

Identification of Let-7f-5p as a novel biomarker of recurrence in non-muscle invasive bladder cancer.

Shee K, Seigne JD, Karagas MR, Marsit CJ, Hinds JW, Schned AR, Pettus JR, Armstrong DA, Miller TW, Andrew AS. Shee K, et al. Among authors: hinds jw. Cancer Biomark. 2020;29(1):101-110. doi: 10.3233/CBM-191322. Cancer Biomark. 2020. PMID: 32623385

8

Selective Induction of Cellular Toxicity and Anti-tumor Efficacy by N-Methylpiperazinyl Diarylidenylpiperidone and its Pro-nitroxide Conjugate through ROS-mediated Mitochondrial Dysfunction and G2/M Cell-cycle Arrest in Human Pancreatic Cancer.

Mast JM, Hinds JW, Tse D, Axelrod K, Kuppusamy ML, Kmiec MM, Bognár B, Kálai T, Kuppusamy P. Mast JM, et al. Among authors: hinds jw. Cell Biochem Biophys. 2020 Jun;78(2):191-202. doi: 10.1007/s12013-020-00919-0. Epub 2020 May 24. Cell Biochem Biophys. 2020. PMID: 32449075

9

Functional heterogeneity of breast fibroblasts is defined by a prostaglandin secretory phenotype that promotes expansion of cancer-stem like cells.

Rudnick JA, Arendt LM, Klebba I, Hinds JW, Iyer V, Gupta PB, Naber SP, Kuperwasser C. Rudnick JA, et al. Among authors: hinds jw. PLoS One. 2011;6(9):e24605. doi: 10.1371/journal.pone.0024605. Epub 2011 Sep 21. PLoS One. 2011. PMID: 21957456 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

9 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year